Literature DB >> 31673820

Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study.

Sonia Guleria1, Allan Jensen2, Anita Toender3,4,5, Susanne K Kjaer1,6.   

Abstract

PURPOSE: The importance of benign ovarian tumors as precursors or risk markers for ovarian cancer is not fully understood. Studies on the association between benign ovarian tumors and ovarian cancer have provided inconclusive results. We examined the overall and histological type-specific risk of ovarian cancer among 158,221 Danish women diagnosed with a benign ovarian tumor during 1978-2016.
METHODS: The study cohort was linked to the Danish Cancer Register to identify all cases of epithelial ovarian cancer, and standardized incidence ratios (SIR) with 95% confidence intervals (CI) were calculated.
RESULTS: After excluding the first year of follow-up, women with benign ovarian tumors did not have an increased risk for overall epithelial ovarian cancer (SIR 1.02; 95% CI 0.93-1.11), as compared with women in the general population. However, we found an increased risk for mucinous ovarian cancer (SIR 2.06; 95% CI 1.67-2.52); both solid and cystic benign ovarian tumors were associated with an increased risk. The risk for mucinous ovarian cancer was increased irrespective of the age at benign ovarian tumors diagnosis and persisted for up to 20 years after the benign ovarian tumor diagnosis. No clear associations for other histological types of ovarian cancer were observed, except for an increased risk for serous ovarian cancer among women diagnosed with benign ovarian tumors at an young age.
CONCLUSIONS: Benign ovarian tumors may be associated with long-term increased risk for mucinous ovarian cancer.

Entities:  

Keywords:  Benign ovarian tumors; Cohort study; Denmark; Ovarian cancer; Ovarian cysts

Mesh:

Year:  2019        PMID: 31673820     DOI: 10.1007/s10552-019-01245-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.

Authors:  Ying Wang; Chenming Yan; Junxia Qi; Chunyan Liu; Juan Yu; Huabin Wang
Journal:  Mol Cell Biochem       Date:  2021-10-30       Impact factor: 3.396

2.  Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies.

Authors:  Jiao Guo; Haoshen Feng; Xi Gu
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 3.  What is new about ovarian malignancies?

Authors:  Kinga Grabska; Izabela Pilarska; Marta Magdalena Fudalej; Andrzej Deptała; Anna Badowska-Kozakiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2021-12-29

Review 4.  Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential.

Authors:  Bei Wang; Wen Xu; Chengyu Hu; Kai Liu; Jinlan Chen; Chong Guo; Chengfu Yuan
Journal:  Genes Dis       Date:  2020-12-02

5.  Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy.

Authors:  Xiandong Leng; Sitai Kou; Yixiao Lin; Andrea R Hagemann; Ian S Hagemann; Premal H Thaker; Lindsay M Kuroki; Carolyn K McCourt; David G Mutch; Cary Siegel; Matthew A Powell; Quing Zhu
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

6.  Implementation of Vaccinomics and In-Silico Approaches to Construct Multimeric Based Vaccine Against Ovarian Cancer.

Authors:  Muhammad Sufyan; Farah Shahid; Faiza Irshad; Anam Javaid; Muhammad Qasim; Usman Ali Ashfaq
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.